Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-22 · accession 0000899243-22-037048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-25 | 2022-11-22+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.02 | -201.6K | 20.32M | -1.0% | -$406.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-22 | S | D | 101,813 | $2.04 | 20,418,075 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-11-23 | S | D | 99,798 | $1.99 | 20,318,277 | D | — | — |